# Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR (V3EA)

**Page:** https://fundology.uk/fund/v3ea · ISIN IE000QUOSE01

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, V3EA (Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR, ISIN IE000QUOSE01) closed at £6.77 on the London Stock Exchange. Its ongoing charge is 0.12% a year (about £12 on £10,000). Over the three years to 13/11/2026 its price changed by +52.2%, or +37.5% after UK CPIH inflation.

## Summary

Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR is an exchange-traded fund (ETF) from Vanguard, launched in 2022. It tracks the FTSE Developed Europe All Cap Choice Index — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£6.77** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | V3EA |
| ISIN | IE000QUOSE01 |
| Also listed as | V3DA (Xetra, euros) |
| Category | European shares |
| Type | ETF |
| Provider | Vanguard |
| Tracks | FTSE Developed Europe All Cap Choice Index |
| Income | Accumulating |
| Ongoing charge | 0.12% a year (£12 per £10,000) |
| Fund size | £114m |
| Launched | 2022 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 16/08/2022 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +11.40% | +7.46% | income reinvested |
| 3 years | +52.21% | +37.51% | price only |

Returns: as reported (delayed data) and worked out from recorded daily closes. Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR in pounds (price, with income reinvested in the fund): 2023 +13.7%, 2024 +4.6%, 2025 +23.3%; 2026 to 13/11/2026 +9.2%. Returns of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +10.7%; to 30/09/2025: +12.8%; to 30/09/2024: +17.7%; to 30/09/2023: +17.4%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2023 | +13.7% | +9.2% | Price |
| 2024 | +4.6% | +1.1% | Price |
| 2025 | +23.3% | +19.1% | Price |
| 2026 to 13/11/2026 | +9.2% | +5.7% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 13.76% | -11.60% |
| 3 years | 12.22% | -11.60% |

## Largest fall

Volatility of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR in pounds, annualised from weekly returns to 13/11/2026: 13.8% over 1 year, 12.2% over 3 years. Largest fall in the price of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR since August 2022, in pounds: −11.6% from 27/02/2026 to 20/03/2026. The lowest 12-month return of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR in pounds (price, with income reinvested in the fund) since August 2022 was +0.1% (12 months to 04/04/2025); the highest was +24.3% (12 months to 10/04/2026). On 13/11/2026 the price of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR was 1.0% below its highest weekly close since August 2022 (07/08/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR 0.12% a year. Compared on 14/11/2026, 187 of the 242 other European share funds charge more, 17 the same and 38 less (share classes counted once).

## Funds tracking the same index

2 funds track FTSE Developed Europe All Cap Choice Index, this one included and share classes counted once; their ongoing charges range from 0.12% to 0.12% a year (13/11/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Vanguard ESG Developed Europe All Cap UCITS ETF -EUR | 0.12% | +11.0% | +34.4% | — |
| Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR (this fund) | 0.12% | +11.4% | — | — |

Returns are as reported, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- Ongoing charges figure (OCF): **0.12%** per year (as of 14/11/2026)
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 31/10/2026, V3EA holds 1,001 positions, according to its published holdings. The largest is ASML at 5.62% of the fund; the ten largest make up 24.8%.

### Top holdings

Largest positions (as of 31/10/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 5.62% |
| 2 | Roche | [RO](https://fundology.uk/stock/RO) | 3.32% |
| 3 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 2.80% |
| 4 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 2.59% |
| 5 | Nestle | [NESN](https://fundology.uk/stock/NESN) | 2.45% |
| 6 | SAP | [SAP](https://fundology.uk/stock/SAP) | 2.13% |
| 7 | Allianz | [ALV](https://fundology.uk/stock/ALV) | 1.72% |
| 8 | Banco Santander | [SAN](https://fundology.uk/stock/SAN) | 1.51% |
| 9 | UBS Group | [UBSG](https://fundology.uk/stock/UBSG) | 1.36% |
| 10 | Unilever | [ULVR](https://fundology.uk/stock/ULVR) | 1.25% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By sector

Added up from the fund’s published holdings, as of 31/10/2026.

| Sector | Weight |
|---|---|
| Financials | 30.9% |
| Health Care | 18.9% |
| Information Technology | 11.3% |
| Industrials | 10.3% |
| Consumer Staples | 8.7% |
| Consumer Discretionary | 6.9% |
| Communication Services | 4.1% |
| Materials | 3.5% |
| Other sectors | 2.8% |
| Not classified | 1.2% |

### By country

Added up from the fund’s published holdings, as of 31/10/2026.

| Country | Weight |
|---|---|
| United Kingdom | 18.3% |
| Switzerland | 17.6% |
| Germany | 12.6% |
| Netherlands | 10.0% |
| France | 8.7% |
| Sweden | 7.1% |
| Spain | 5.3% |
| Italy | 5.2% |
| Other countries | 12.5% |
| Not classified | 1.2% |

### By type of asset

Added up from the fund’s published holdings, as of 31/10/2026.

| Type of asset | Weight |
|---|---|
| Equity | 97.3% |
| Cash and money market | 1.2% |

The 833 holdings on record (of 1,001 reported): https://fundology.uk/fund/v3ea/holdings

## Questions people ask

**What is the ongoing charge of V3EA?**

The ongoing charge of V3EA is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Vanguard ESG Developed Europe All Cap UCITS ETF AccumEUR 0.12% a year. Compared on 14/11/2026, 187 of the 242 other European share funds charge more, 17 the same and 38 less (share classes counted once).

**What does V3EA track?**

V3EA tracks the FTSE Developed Europe All Cap Choice Index — large and medium-sized European companies.

**Is V3EA accumulating or distributing?**

V3EA is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of V3EA?**

The ISIN of V3EA is IE000QUOSE01. An ISIN identifies one exact share class of a fund; V3EA is its ticker on the London Stock Exchange. The same share class is also listed as V3DA (Xetra, euros).

**What does V3EA hold?**

As of 31/10/2026, V3EA holds 1,001 positions, according to its published holdings. The largest is ASML at 5.62% of the fund; the ten largest make up 24.8%. Its ten largest holdings are ASML (5.62%), Roche (3.32%), Novartis (2.80%), AstraZeneca (2.59%), Nestle (2.45%), SAP (2.13%), Allianz (1.72%), Banco Santander (1.51%), UBS Group (1.36%) and Unilever (1.25%).

**What were V3EA’s returns in each of the last five years?**

Calendar-year returns of V3EA in pounds (price, with income reinvested in the fund): 2023 +13.7%, 2024 +4.6%, 2025 +23.3%; 2026 to 13/11/2026 +9.2%. Past performance is not a guide to future returns.

**How has V3EA done after inflation?**

Over the three years to 13/11/2026 V3EA’s price changed by +52.2%, or +37.5% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at Vanguard](https://www.vanguard.co.uk/professional/product/etf/equity/E034/esg-developed-europe-all-cap-ucits-etf-eur-accumulating)
- [Key investor information document (KIID)](https://fund-docs.vanguard.com/ie000quose01-en.pdf)
- [Factsheet](https://fund-docs.vanguard.com/ESG_Developed_Europe_All_Cap_UCITS_ETF_EUR_Accumulating_E034_EU_INT_UK_EN.pdf)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.